Stock Report

Eris Lifesciences Ltd posts consolidated PAT of Rs. 118.39 crore in Q2FY22



Posted On : 2021-10-29 17:52:38( TIMEZONE : IST )

Eris Lifesciences Ltd posts consolidated PAT of Rs. 118.39 crore in Q2FY22

The Board of Directors of Eris Lifesciences Limited, at its meeting held today have approved the unaudited Consolidated financial results of the company for the period ended September 30, 2021.

For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹ 366.657 crore, against ₹332.076 crore in the corresponding quarter of the previous year (YoY) and ₹355.135 crore in previous quarter (QoQ).

For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹118.393 crore, against ₹107.720 crore in the corresponding quarter of the previous year (YoY) and ₹106.659 crore in previous quarter (QoQ).

For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹8.71, against ₹7.93 in the corresponding quarter of the previous year (YoY) and ₹7.85 in previous quarter (QoQ).

Financials Q2 FY2022 Q1 FY2022 QoQ % Change Q2 FY2021 YoY % Change
Total Income ₹ 366.657 crs ₹355.135 crs Up Tick / Down Tick3.24% ₹332.076 crs Up Tick / Down Tick10.41%
Net Profit ₹118.393 crs ₹106.659 crs Up Tick / Down Tick11.00% ₹107.720 crs Up Tick / Down Tick9.91 %
EPS ₹8.71 ₹7.85 Up Tick / Down Tick10.96% ₹7.93 Up Tick / Down Tick9.84%

For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹721.792 crore, against ₹626.657 crore in the previous year (YoY) (Half Year Ended FY 2021).

The net profit / (loss) was at ₹225.052 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹196.738 crore in the previous year (YoY) (Half Year Ended FY 2021).

The Earnings Per Share stood at ₹16.56 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹14.48 in the previous year (YoY) (Half Year Ended FY 2021).

Financials Half Year Ended FY2022 Half Year Ended FY2021 % Change
Total Income ₹721.792 crs ₹626.657 crs Up Tick / Down Tick15.18%
Net Profit ₹225.052 crs ₹196.738 crs Up Tick / Down Tick14.39%
EPS ₹16.56 ₹14.48 Up Tick / Down Tick14.36%

Shares of Eris Lifesciences Limited was last trading in BSE at Rs. 817.30 as compared to the previous close of Rs. 782.55. The total number of shares traded during the day was 7374 in over 1270 trades.

The stock hit an intraday high of Rs. 835.00 and intraday low of 762.10. The net turnover during the day was Rs. 5802094.00.

Source : Equity Bulls

Keywords

ErisLifesciences Q2FY22 H1FY22 ResultUpdate